USPTO serial 88712135
JCR
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- STRICKLAND, CODY S
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with JCR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Ashiya-shi, Hyogo, JP
Ashiya-shi, Hyogo, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher I. Donahue
Christopher I. Donahue OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P.1940 DUKE STREETALEXANDRIA, VA 22314UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of diseases and disorders affecting the central nervous system, peripheral nervous system, cardiovascular system, endocrine system, excretory system, digestive system, respiratory system, lymphatic system, integumentary system, muscular system, reproductive system, skeletal system, immune system, urinary system, and sensory organs; pharmaceutical preparations for the treatment and prevention of inflammation, inflammatory diseases, auto-immune diseases, neurological disorders, metabolic disorders, dermatological disorders, renal and urological disorders, genetic disorders, tumors, infectious diseases, lysosomal diseases, and graft-versus-host disease; preparations for destroying vermin; fungicides, herbicides; chemical reagents for medical purposes or veterinary purposes | ACTIVE | — |
| 010 | Medical apparatus and instruments for use in the treatment of inflammation, inflammatory diseases, auto-immune diseases, neurological disorders, metabolic disorders, dermatological disorders, renal and urological disorders, genetic disorders, tumors, infectious diseases, lysosomal diseases, and graft-versus-host disease | ACTIVE | — |
| 040 | Custom manufacture of pharmaceuticals and chemicals; custom manufacture of chemical reagents for scientific, laboratory, analysis, research, testing, inspection, detecting and verification use | ACTIVE | — |
| 042 | Medical research; chemical research; chemistry consultation; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; chemical analysis; conducting clinical trials for others; testing the functionality of machines; research on machines; designing of machines, apparatus and instruments for medical purposes, including their parts, or systems composed of such machines, apparatus and instruments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by JCR PHARMACEUTICALS CO., LTD.
- Other trademarks owned by JCR PHARMACEUTICALS CO., LTD.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named JCR
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 3, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 3, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 17, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 15, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 15, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 15, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 9, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 7, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 7, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 7, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 10, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 8, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 8, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 8, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 26, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 24, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 24, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 24, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 1, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 6, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 6, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 16, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 1, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 20, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 19, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 4, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 21, 2020 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jan 20, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jan 7, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Dec 7, 2019 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 6, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2019 | NWAP | NEW APPLICATION ENTERED | — |